Does a patient’s insurance status affect a physician’s decision to prescribe evidence-based therapies for CAD?
Archives for January 2013RSS
This week’s topics include using hospital readmission as a quality marker and the cardiovascular safety of peginesatide for anemia in patients with CKD.
Monika Safford discusses the behavioral mechanisms that most contribute to the association between depression and MI or death in those with CHD.
The researcher and EP who first documented problems with St. Jude next generation leads reacts to the FDA’s recent letter to the company and explains what he is doing for patients who have received these devices.
Appropriate Use or Defensive Medicine? (25 Jan 2013)Sarah C. Hull, MD, MBE (Master of Bioethics)
Is the practice of defensive medicine overriding the implementation of appropriate use to the detriment of economics, patient care, and medical education?
Hospital Readmissions May Be Just the Tip of the Iceberg (24 Jan 2013)Anita Vashi, MD, MPH
Do you know when your patients end up back in the ED but are not rehospitalized?
Is Renal Denervation a cure? A likely overused “magic bullet” in patients who should receive more behavior modification and drug treatment? Where exactly should it fit in our arsenal? John Ryan interviews Murray David Esler
For which patients is the Watchman left-atrial appendage closure device a better alternative to warfarin and other anticoagulant medications?
This week’s topics include a review of drug-eluting stents and a summary of hypertrophic cardiomyopathy.
Observing media coverage of a new study, Harlan Krumholz wonders if the spin misses the point of the research.